
QLINE
Q-LINE BIOTECH LIMITED
- IPO Status
- Closed
- Open Date
- 21 May 2026
- Close Date
- 25 May 2026
IPO Details
- Min. Investment
- ₹2,74,400
- Price Band
- ₹326 - ₹343
- Lot Size
- 400 shares
- Issue Size
- ₹214 Cr
- Face Value
- 10
- IPO Doc
- —
Schedule
- IPO open21 May 2026
- IPO close date25 May 2026
- Allotment date26 May 2026
- Funds unblock or debit27 May 2026
- Listing date29 May 2026
Financial Performance
- Revenue
- Profit
FAQs
Q-LINE BIOTECH LIMITED IPO is a SME IPO aggregating up to ₹214 Cr, with equity shares of face value ₹10 each. The shares are proposed to be listed on NSE.
The Q-LINE BIOTECH LIMITED IPO opened on 21 May 2026 and closed on 25 May 2026. IPO Period: 21 May 2026 – 25 May 2026.
The price band for the Q-LINE BIOTECH LIMITED IPO is ₹326 to ₹343 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 400 shares. At the upper price band of ₹343, the minimum investment required is ₹2,74,400.
Particular Details Lot Size 400 shares Minimum Application 800 shares Price Band ₹326 – ₹343 Minimum Investment ₹2,74,400 Here is the timeline for the Q-LINE BIOTECH LIMITED IPO:
IPO Event Date IPO Opens 21 May 2026 IPO Closes 25 May 2026 UPI Mandate Deadline 25 May 2026, 5:00 PM Basis of Allotment 26 May 2026 Refund Initiation 27 May 2026 Shares Credited 27 May 2026 Listing Date 29 May 2026 The basis of allotment for the Q-LINE BIOTECH LIMITED IPO is expected to be finalised on 26 May 2026. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: Purva Sharegistry.
The equity shares of Q-LINE BIOTECH LIMITED are proposed to be listed on NSE. Proposed Listing Date: 29 May 2026.
The key financial performance of Q-LINE BIOTECH LIMITED is:
Financial Year Revenue Profit FY24 ₹203.65 Cr ₹34.44 Cr FY25 ₹346.46 Cr ₹19.21 Cr FY26 ₹398.17 Cr ₹55.72 Cr Revenue CAGR: 39.8% | Profit CAGR: 27.2%. Figures are as disclosed in the company's offer documents.


